Back to today’s briefing

Story perspectives

FDA Approves Generic Mifepristone Amid Safety Concerns

10/5/2025

25 3 Full Breakdown

Summary

Story summary

The FDA approved Evita Solutions' generic mifepristone amid safety reviews.
Health Secretary Robert F. Kennedy Jr. said federal law mandates approval if identical to the brand, leaving limited discretion for the FDA.
Critics, including Republican lawmakers, say move ignores promised safety reviews and raises risks.
Proponents note mifepristone is essential for women's health, with studies showing rare serious complications.

1 of 1

Story summary

The FDA approved Evita Solutions' generic mifepristone amid safety reviews.
Health Secretary Robert F. Kennedy Jr. said federal law mandates approval if identical to the brand, leaving limited discretion for the FDA.
Critics, including Republican lawmakers, say move ignores promised safety reviews and raises risks.
Proponents note mifepristone is essential for women's health, with studies showing rare serious complications.